Unsurprisingly, CCN1 knockdown resulted in the downregulations of CD44 and YKL40, two well‐defined MES phenotype markers in GSCs and GBM cell lines (Figure 2A and Supplementary Fig. S5A). Here, CCN1 is linked to glioblastoma.